How does insulin interact with lipid nanoparticles in drug delivery systems, and what are the advancements in enhancing insulin bioavailability and efficacy through this technology?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Insulin, when encapsulated in lipid nanoparticles (LNPs), can be protected from enzymatic degradation, enhancing its bioavailability. Recent advancements include targeting LNPs to specific cells to improve insulin efficacy.